ClinVar Miner

Submissions for variant NM_000071.2(CBS):c.*22C>T (rs1051316)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000483992 SCV000571282 uncertain significance not specified 2016-08-08 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in an alternate transcript of the CBS gene. The c.*18+4 C>T variant has also not been reported as a pathogenic variant or as a benign variant to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations.The c.*18+4 C>T variant occurs in the +4 position of a splice donor site for intron 17 in the alternate transcript noted above. This position is located downstream of the natural termination codon in all transcripts and is in the 3'UTR of the default transcript (NM000071.2). In this alternate transcript, the sequence of intron 17 is predicted to be spliced out of the 3'UTR, whereas all other transcripts retain that sequence. This variant occurs at a position that is not conserved across species and where thymidine (T) is tolerated in multiple species. Several in silico splice prediction programs do not recognize this splice donor site in the alternate trancript; those that do are inconsistent in their predictions as to whether this variant has an impact on gene splicing. Nevertheless, in the absence of functional mRNA studies, the physiological consequence of this variant cannot be precisely determined. In addition, if normal splicing is disrupted, the biological and clinical consequence of aberrant splicing in this alternate transcript of CBS is unknown, as no other variants exclusive to this transcript have been reported to our knowledge.Therefore, based on the currently available information, it is unclear whether this is a pathogenic or rare benign variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.